RAPIBLYK

GrowthSM

landiolol

NDAINTRAVENOUSPOWDER
Approved
Nov 2024
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Apr 25, 2034
99 months away
Patent Expiry
Apr 25, 2034
Exclusivity Expiry
Nov 22, 2029

Patent Records (1)

Patent #ExpiryTypeUse Code
10722516
Apr 25, 2034
U-4235
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers